Dual-targeting CRISPR-CasRx reduces C9orf72 ALS/FTD sense and antisense repeat RNAs in vitro and in vivo
Preprint in bioRxiv (January 2024)
The most recent citing publications are shown below. View all 50 publications that cite this research output on Dimensions.
Preprint in bioRxiv (January 2024)
Book chapter (January 2024)
Article in Molecular Neurodegeneration (January 2024)